Clinical Trial: Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07344597) titled 'Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer' on Sept. 25, 2025.

Brief Summary: To compare the efficacy and safety of two hypofractionated adjuvant radiotherapy regimens 34 Gy in 10

fractions versus 40.05 Gy in 15 fractions in patients with breast cancer treated at the South Egypt Cancer

Institute.

Study Start Date: Jan., 2026

Study Type: OBSERVATIONAL

Condition: Breast Cancer

Intervention: DEVICE: radiotherapy

Hypofractionated Adjuvant Radiotherapy in 2 versus 3 Weeks of Breast Cancer and effect skin toxicity and over all survival

Recruitment Status: NOT_YET_...